Health Catalyst, Inc. HCAT
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -13.88% | -7.54% | -2.83% | 1.48% | 4.64% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -13.88% | -7.54% | -2.83% | 1.48% | 4.64% |
| Cost of Revenue | -17.18% | -16.38% | -10.92% | -5.03% | 2.07% |
| Gross Profit | -10.23% | 2.83% | 6.70% | 9.06% | 7.63% |
| SG&A Expenses | -24.43% | -19.06% | -0.62% | 0.31% | -0.96% |
| Depreciation & Amortization | -4.55% | 7.37% | 16.35% | 21.89% | 15.47% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -18.61% | -15.67% | -7.01% | -2.66% | 0.27% |
| Operating Income | 47.80% | 61.68% | 32.55% | 25.58% | 20.26% |
| Income Before Tax | -88.80% | -164.53% | -266.01% | -156.27% | -34.52% |
| Income Tax Expenses | -25.68% | 157.62% | 110.34% | 115.02% | 745.64% |
| Earnings from Continuing Operations | -87.78% | -164.50% | -265.08% | -156.07% | -35.99% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -87.78% | -164.50% | -265.08% | -156.07% | -35.99% |
| EBIT | 47.80% | 61.68% | 32.55% | 25.58% | 20.26% |
| EBITDA | 138.52% | 164.95% | 115.31% | 86.22% | 53.40% |
| EPS Basic | -78.40% | -143.44% | -223.35% | -119.42% | -17.17% |
| Normalized Basic EPS | 44.26% | 47.55% | 17.89% | 9.02% | 2.43% |
| EPS Diluted | -78.39% | -143.71% | -223.70% | -119.78% | -17.47% |
| Normalized Diluted EPS | 44.39% | 47.55% | 17.89% | 9.02% | 2.43% |
| Average Basic Shares Outstanding | 8.12% | 10.32% | 13.13% | 16.14% | 14.89% |
| Average Diluted Shares Outstanding | 8.32% | 10.32% | 13.13% | 16.14% | 14.89% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |